TR199903271T2 - Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�. - Google Patents
Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.Info
- Publication number
- TR199903271T2 TR199903271T2 TR1999/03271T TR9903271T TR199903271T2 TR 199903271 T2 TR199903271 T2 TR 199903271T2 TR 1999/03271 T TR1999/03271 T TR 1999/03271T TR 9903271 T TR9903271 T TR 9903271T TR 199903271 T2 TR199903271 T2 TR 199903271T2
- Authority
- TR
- Turkey
- Prior art keywords
- tozlar
- soluma
- prolipozom
- tokoferol
- karl
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 abstract 1
- 229960002848 formoterol Drugs 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88441997A | 1997-06-27 | 1997-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199903271T2 true TR199903271T2 (en) | 2000-08-21 |
Family
ID=25384589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1999/03271T TR199903271T2 (en) | 1997-06-27 | 1998-06-08 | Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1001749A1 (et) |
| JP (1) | JP2002510311A (et) |
| KR (1) | KR20010014163A (et) |
| CN (1) | CN1260713A (et) |
| AU (1) | AU729100B2 (et) |
| BR (1) | BR9810280A (et) |
| CA (1) | CA2295028A1 (et) |
| EE (1) | EE9900601A (et) |
| HU (1) | HUP0003207A3 (et) |
| ID (1) | ID23192A (et) |
| IL (1) | IL133478A0 (et) |
| IS (1) | IS5304A (et) |
| NO (1) | NO996439L (et) |
| NZ (1) | NZ501672A (et) |
| PL (1) | PL337723A1 (et) |
| SK (1) | SK184899A3 (et) |
| TR (1) | TR199903271T2 (et) |
| WO (1) | WO1999000111A1 (et) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| EP1138310A1 (de) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Pro-liposomen |
| EP1138311A1 (de) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Pro-liposomen |
| EP1138313A1 (de) * | 2000-03-28 | 2001-10-04 | Primacare S.A. | Pro-liposomen |
| ES2462541T3 (es) * | 2005-06-09 | 2014-05-23 | Meda Ab | Método y composición para el tratamiento de trastornos inflamatorios |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| WO2014180827A1 (en) * | 2013-05-06 | 2014-11-13 | Dsm Ip Assets B. V. | Powderous vitamin e formulation |
| WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| CN105078963B (zh) * | 2015-09-29 | 2018-06-22 | 中山大学 | α-生育酚在制备治疗血吸虫病药物中的应用 |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| AU2019308326B2 (en) | 2018-07-20 | 2025-07-31 | Lipocine Inc. | Liver disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05507090A (ja) * | 1990-05-08 | 1993-10-14 | リポサーム テクノロジー インコーポレイテッド | 直接噴霧乾燥された薬剤／脂質粉末組成物 |
| AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
-
1998
- 1998-06-08 EE EEP199900601A patent/EE9900601A/et unknown
- 1998-06-08 KR KR1019997012234A patent/KR20010014163A/ko not_active Withdrawn
- 1998-06-08 HU HU0003207A patent/HUP0003207A3/hu unknown
- 1998-06-08 CN CN98806377A patent/CN1260713A/zh active Pending
- 1998-06-08 JP JP50548099A patent/JP2002510311A/ja active Pending
- 1998-06-08 SK SK1848-99A patent/SK184899A3/sk unknown
- 1998-06-08 TR TR1999/03271T patent/TR199903271T2/xx unknown
- 1998-06-08 WO PCT/SE1998/001090 patent/WO1999000111A1/en not_active Ceased
- 1998-06-08 CA CA002295028A patent/CA2295028A1/en not_active Abandoned
- 1998-06-08 PL PL98337723A patent/PL337723A1/xx unknown
- 1998-06-08 NZ NZ501672A patent/NZ501672A/en unknown
- 1998-06-08 AU AU79456/98A patent/AU729100B2/en not_active Ceased
- 1998-06-08 ID IDW991656A patent/ID23192A/id unknown
- 1998-06-08 EP EP98929963A patent/EP1001749A1/en not_active Withdrawn
- 1998-06-08 BR BR9810280-0A patent/BR9810280A/pt not_active IP Right Cessation
- 1998-06-08 IL IL13347898A patent/IL133478A0/xx unknown
-
1999
- 1999-12-15 IS IS5304A patent/IS5304A/is unknown
- 1999-12-23 NO NO996439A patent/NO996439L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010014163A (ko) | 2001-02-26 |
| IS5304A (is) | 1999-12-15 |
| AU729100B2 (en) | 2001-01-25 |
| HUP0003207A3 (en) | 2001-03-28 |
| SK184899A3 (en) | 2000-05-16 |
| CN1260713A (zh) | 2000-07-19 |
| BR9810280A (pt) | 2000-09-12 |
| NO996439L (no) | 2000-02-28 |
| IL133478A0 (en) | 2001-04-30 |
| CA2295028A1 (en) | 1999-01-07 |
| AU7945698A (en) | 1999-01-19 |
| JP2002510311A (ja) | 2002-04-02 |
| NO996439D0 (no) | 1999-12-23 |
| NZ501672A (en) | 2001-06-29 |
| WO1999000111A1 (en) | 1999-01-07 |
| PL337723A1 (en) | 2000-08-28 |
| HUP0003207A2 (hu) | 2001-02-28 |
| EE9900601A (et) | 2000-08-15 |
| EP1001749A1 (en) | 2000-05-24 |
| ID23192A (id) | 2000-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR199903271T2 (en) | Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�. | |
| TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
| BR0314354A (pt) | Formação para gentes lipofìlicos | |
| PT1093819E (pt) | Compostos e composicoes para fornecimento de agentes activos | |
| DE69530926D1 (de) | Mittel zur förderung des haarwachstums | |
| PT1129093E (pt) | Derivados de pirazpolopirimidinona para o tratamento da impotencia | |
| BR9904719A (pt) | Composição para incrementar a permeabilidade de agentes tópicos à pele | |
| YU49315B (sh) | Inhibitor protein kinaze c, njegove farmaceutske formulacije i postupak za dobijanje | |
| AR020345A1 (es) | Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones. | |
| PT902789E (pt) | Derivados de androsteno | |
| ID22878A (id) | Komposisi aktif secara terapi | |
| BR9811099A (pt) | Inibidores de urocinase | |
| DE69807065D1 (de) | Topische mittel | |
| BR9804027A (pt) | Novos beta-ceto ésteres | |
| EP0671911A4 (en) | CARBOXYPEPTIDYL DERIVATIVES AS AN ANTIDEGENERATIVE ACTIVE SUBSTANCES. | |
| EP0843592A4 (en) | DEHALOGENATION OF HYDROCARBONS PRESENT IN AQUEOUS COMPOSITIONS | |
| SE9800729L (sv) | Ny topikal formulering I | |
| UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
| BR9707551A (pt) | Composições contendo um antifúngico e um composto de enxofre. | |
| PT766557E (pt) | Composicoes de aplicacao topica compreendendo n-acetil-cisteina | |
| BR9809848A (pt) | Composição | |
| DE69822366D1 (de) | Wässrige Emulsionszusammensetzung | |
| BR9901392A (pt) | Hidroxi-metil-hexanonas como agentes aromatizantes. | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| DE69314463D1 (de) | Hautregenerierende kosmetische zusammensetzung |